Healthcare professionals will gain an understanding of dietary and lifestyle considerations to help patients improve tolerability and improve outcomes with the use of GLP-1 receptor agonists for specific indications, such as weight loss
Who May Be at Higher Risk of Eye Complications Not everyone taking GLP-1 medications faces the same level of risk for eye complications
Peak weight loss effects are usually observed at 1218 months of continuous treatment, particularly with higher-dose formulations like semaglutide 2
It may cause anemia, characterized by fatigue, weakness, and pale skin due to a lack of healthy red blood cells
5.2.3 Thyroid cancer Increased production of ROS has been shown to favour cancer development (111)
capillary voltage, 3,500 V